Pharma Journalist - Page 768 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

PCMA conveys response to Scott Gottlieb’s comments on Biosimilars

FDA Commissioner Scott Gottlieb vows to commit to market review of Essure

Zydus partners Medicure to launch its NDA product, ZYPITAMAG

Perrigo receives final approval from FDA for OTC equivalent of Mucinex DM

Veloxis submits sNDA to FDA seeking new indication for ENVARSUS XR

Biohaven enrolls first patient in Phase 3 Clinical Trial to assess Rimegepant Zydis ODT to treat Migraine

Apexigen and Pediatric Brain Tumor Consortium collaborate to evaluate APX005M in Brain tumor children

Citius Pharmaceuticals conveys progress in Hemorroid Treatment Program